2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone has been researched along with Leukemia L5178 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nishimura, T; Sugimoto, Y; Suzuki, H; Tanaka, N; Yamaki, H | 1 |
1 other study(ies) available for 2-crotonyloxymethyl-(4r,5r,6r)-4,5,6-trihydroxycyclohex- 2-enone and Leukemia L5178
Article | Year |
---|---|
Mechanism of action of 2-crotonyloxymethyl-4,5,6-trihydroxycyclohex-2-enone, a SH inhibitory antitumor antibiotic, and its effect on drug-resistant neoplastic cells.
Topics: Animals; Antibiotics, Antineoplastic; Cyclohexanes; Cyclohexanones; DNA-Directed DNA Polymerase; DNA, Neoplasm; Doxorubicin; Drug Resistance; Leukemia L5178; Leukemia, Experimental; Neoplasm Proteins; Phosphodiesterase Inhibitors; RNA, Neoplasm | 1982 |